» Authors » John Edwards

John Edwards

Explore the profile of John Edwards including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 140
Citations 1952
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bordvik D, Prior Y, Bamford R, Berenbaum F, Bjork M, Blanck T, et al.
Osteoarthr Cartil Open . 2025 Feb; 7(1):100578. PMID: 39995586
Background: People with hand osteoarthritis (OA) often have poor access to recommended treatments. To enhance care quality, quality indicators (QIs) based on clinical recommendations are essential. Current QI sets, like...
2.
Orr D, Anderson R, Jensen A, Peterson T, Edwards J, Bowden A
Spine J . 2025 Feb; PMID: 39900249
Background Context: Since the early 2000s, various expandable spinal fusion cages have been developed to facilitate less invasive procedures, however, expandable cages have often been evaluated as a homogeneous group,...
3.
Houda I, Bahce I, Dickhoff C, Kroese T, Kroeze S, Mariolo A, et al.
Lung Cancer . 2024 Dec; 199:108061. PMID: 39705827
Introduction: The EORTC-Lung Cancer Group initiated a Delphi consensus process to establish a consensual definition of resectable stage III non-small cell lung cancer (NSCLC) for the use in clinical trials,...
4.
Hoffmann H, Nicholson A, Detterbeck F, Tsao M, Ostrowski M, Rami-Porta R, et al.
J Thorac Oncol . 2024 Dec; PMID: 39675507
Objectives: The study aimed to assess the opinion of pathologists and thoracic surgeons of the International Association for the Study of Lung Cancer regarding the application and interpretation of the...
5.
Linares Diaz J, Edwards J, Deleu A, Giaj-Levra N, Prisciandaro E, Roch B, et al.
Cancers (Basel) . 2024 Aug; 16(15). PMID: 39123401
Patients with stage III NSCLC with N2 lymph node involvement carry a complex and diverse disease entity. Challenges persist in the areas of diagnosis, staging, multimodal management, and the determination...
6.
Caliskan Y, Ozluk Y, Kurashima K, Mirioglu S, Dirim A, Hurdogan O, et al.
Genes (Basel) . 2024 Jun; 15(6). PMID: 38927709
Background: Homozygosity for rs893403-GG genotype is linked to an increased risk of allograft rejection after kidney transplantation. Ischemia-reperfusion of the kidney allograft leads to long term infiltration of activated and...
7.
Scheinberg P, Cle D, Kim J, Nur E, Yenerel M, Barcellini W, et al.
Am J Hematol . 2024 Jun; 99(9):1757-1767. PMID: 38924124
Crovalimab, a novel C5 inhibitor, allows for low-volume, every-4- week, subcutaneous self-administration. COMMODORE 1 (NCT04432584) is a phase 3, global, randomized trial evaluating crovalimab versus eculizumab in C5 inhibitor-experienced patients...
8.
Lim E, Waller D, Lau K, Steele J, Pope A, Ali C, et al.
Lancet Respir Med . 2024 May; 12(6):457-466. PMID: 38740044
Background: Extended pleurectomy decortication for complete macroscopic resection for pleural mesothelioma has never been evaluated in a randomised trial. The aim of this study was to compare outcomes after extended...
9.
Brubaker A, Sellers M, Abt P, Croome K, Merani S, Wall A, et al.
JAMA Surg . 2024 Apr; 159(6):677-685. PMID: 38568597
Importance: Normothermic regional perfusion (NRP) is an emerging recovery modality for transplantable allografts from controlled donation after circulatory death (cDCD) donors. In the US, only 11.4% of liver recipients who...
10.
Simkins J, Holden M, Babatunde O, White S, Nicholls E, Long A, et al.
Musculoskeletal Care . 2024 Mar; 22(1):e1873. PMID: 38453169
Introduction: Osteoarthritis is the commonest form of chronic joint pain, which patients often self-manage before seeking healthcare advice. Patients frequently seek advice from community pharmacies, and a recent policy has...